A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia
- PMID: 32101259
- PMCID: PMC7240357
- DOI: 10.1001/jamacardio.2020.0013
A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia
Erratum in
-
Errors in Figures.JAMA Cardiol. 2020 May 1;5(5):613. doi: 10.1001/jamacardio.2020.0526. JAMA Cardiol. 2020. PMID: 32211817 Free PMC article. No abstract available.
Abstract
Importance: Low-density lipoprotein cholesterol (LDL-C), a key cardiovascular disease marker, is often estimated by the Friedewald or Martin equation, but calculating LDL-C is less accurate in patients with a low LDL-C level or hypertriglyceridemia (triglyceride [TG] levels ≥400 mg/dL).
Objective: To design a more accurate LDL-C equation for patients with a low LDL-C level and/or hypertriglyceridemia.
Design, setting, and participants: Data on LDL-C levels and other lipid measures from 8656 patients seen at the National Institutes of Health Clinical Center between January 1, 1976, and June 2, 1999, were analyzed by the β-quantification reference method (18 715 LDL-C test results) and were randomly divided into equally sized training and validation data sets. Using TG and non-high-density lipoprotein cholesterol as independent variables, multiple least squares regression was used to develop an equation for very low-density lipoprotein cholesterol, which was then used in a second equation for LDL-C. Equations were tested against the internal validation data set and multiple external data sets of either β-quantification LDL-C results (n = 28 891) or direct LDL-C test results (n = 252 888). Statistical analysis was performed from August 7, 2018, to July 18, 2019.
Main outcomes and measures: Concordance between calculated and measured LDL-C levels by β-quantification, as assessed by various measures of test accuracy (correlation coefficient [R2], root mean square error [RMSE], mean absolute difference [MAD]), and percentage of patients misclassified at LDL-C treatment thresholds of 70, 100, and 190 mg/dL.
Results: Compared with β-quantification, the new equation was more accurate than other LDL-C equations (slope, 0.964; RMSE = 15.2 mg/dL; R2 = 0.9648; vs Friedewald equation: slope, 1.056; RMSE = 32 mg/dL; R2 = 0.8808; vs Martin equation: slope, 0.945; RMSE = 25.7 mg/dL; R2 = 0.9022), particularly for patients with hypertriglyceridemia (MAD = 24.9 mg/dL; vs Friedewald equation: MAD = 56.4 mg/dL; vs Martin equation: MAD = 44.8 mg/dL). The new equation calculates the LDL-C level in patients with TG levels up to 800 mg/dL as accurately as the Friedewald equation does for TG levels less than 400 mg/dL and was associated with 35% fewer misclassifications when patients with hypertriglyceridemia (TG levels, 400-800 mg/dL) were categorized into different LDL-C treatment groups.
Conclusions and relevance: The new equation can be readily implemented by clinical laboratories with no additional costs compared with the standard lipid panel. It will allow for more accurate calculation of LDL-C level in patients with low LDL-C levels and/or hypertriglyceridemia (TG levels, ≤800 mg/dL) and thus should improve the use of LDL-C level in cardiovascular disease risk management.
Conflict of interest statement
Figures




Comment in
-
Methods of Calculating Low-Density Lipoprotein Cholesterol Level.JAMA Cardiol. 2020 May 1;5(5):502-503. doi: 10.1001/jamacardio.2020.0042. JAMA Cardiol. 2020. PMID: 32101263 No abstract available.
-
Accuracy of New Equation to Calculate Low-Density Lipoprotein Cholesterol-Reply.JAMA Cardiol. 2021 Jan 1;6(1):122-123. doi: 10.1001/jamacardio.2020.4445. JAMA Cardiol. 2021. PMID: 32997101 No abstract available.
-
Accuracy of New Equation to Calculate Low-Density Lipoprotein Cholesterol.JAMA Cardiol. 2021 Jan 1;6(1):121-122. doi: 10.1001/jamacardio.2020.4411. JAMA Cardiol. 2021. PMID: 32997104 No abstract available.
-
Accuracy of New Equation to Calculate Low-Density Lipoprotein Cholesterol.JAMA Cardiol. 2021 Jan 1;6(1):121. doi: 10.1001/jamacardio.2020.4408. JAMA Cardiol. 2021. PMID: 32997117 No abstract available.
Similar articles
-
Correlation of extended Martin/Hopkins equation with a direct homogeneous assay in assessing low-density lipoprotein cholesterol in patients with hypertriglyceridemia.J Clin Lab Anal. 2023 Sep;37(17-18):e24963. doi: 10.1002/jcla.24963. Epub 2023 Sep 7. J Clin Lab Anal. 2023. PMID: 37679962 Free PMC article.
-
Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels.JAMA Netw Open. 2021 Oct 1;4(10):e2128817. doi: 10.1001/jamanetworkopen.2021.28817. JAMA Netw Open. 2021. PMID: 34709388 Free PMC article.
-
Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis.Clin Biochem. 2019 Feb;64:24-29. doi: 10.1016/j.clinbiochem.2018.10.011. Epub 2018 Oct 24. Clin Biochem. 2019. PMID: 30365923
-
Accuracy of 23 Equations for Estimating LDL Cholesterol in a Clinical Laboratory Database of 5,051,467 Patients.Glob Heart. 2023 Jun 19;18(1):36. doi: 10.5334/gh.1214. eCollection 2023. Glob Heart. 2023. PMID: 37361322 Free PMC article.
-
How should low-density lipoprotein cholesterol be calculated in 2022?Curr Opin Lipidol. 2022 Aug 1;33(4):237-256. doi: 10.1097/MOL.0000000000000833. Curr Opin Lipidol. 2022. PMID: 35942811 Review.
Cited by
-
Accuracy of Small Dense Low-density Lipoprotein-cholesterol Concentration Estimated via Sampson's Equation in Healthy Subjects and Patients with Diabetes.J Atheroscler Thromb. 2023 Aug 1;30(8):979-989. doi: 10.5551/jat.63865. Epub 2022 Oct 8. J Atheroscler Thromb. 2023. PMID: 36216531 Free PMC article.
-
A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test.Clin Chem. 2021 Jul 6;67(7):987-997. doi: 10.1093/clinchem/hvab048. Clin Chem. 2021. PMID: 33876239 Free PMC article.
-
Differences between repeated lipid profile measurements in a tertiary hospital over a short time period.Lipids Health Dis. 2024 Jan 27;23(1):30. doi: 10.1186/s12944-024-02022-2. Lipids Health Dis. 2024. PMID: 38281001 Free PMC article.
-
Exploring Utilization and Establishing Reference Intervals for the Apolipoprotein B Test in the Korean Population.Diagnostics (Basel). 2023 Oct 12;13(20):3194. doi: 10.3390/diagnostics13203194. Diagnostics (Basel). 2023. PMID: 37892015 Free PMC article.
-
Do Triglyceride-Rich Lipoproteins Equal Low-Density Lipoproteins in Risk of ASCVD?Curr Atheroscler Rep. 2023 Nov;25(11):795-803. doi: 10.1007/s11883-023-01153-8. Epub 2023 Sep 28. Curr Atheroscler Rep. 2023. PMID: 37768410 Review.
References
-
- Langlois MR, Chapman MJ, Cobbaert C, et al. ; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative . Quantifying atherogenic lipoproteins: current and future challenges in the era of personalized medicine and very low concentrations of LDL cholesterol: a consensus statement from EAS and EFLM. Clin Chem. 2018;64(7):1006-1033. doi:10.1373/clinchem.2018.287037 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous